Bausch Health Companies Inc (NYSE:BHC)
| 24.80 Delayed Data As of Jan 27 |  -1.65 / -6.24%Today’s Change | 11.15 Today|||52-Week Range 29.68 | +19.23% Year-to-Date |
Latest BHC News | Press Releases
| Bausch Health (BHC) Dry Eye Treatment Study Enrollment Complete Jan 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 26.45 |
| Today’s open | 26.01 |
| Day’s range | 24.58 - 26.13 |
| Volume | 8,264,616 |
| Average volume (3 months) | 3,861,292 |
| Market cap | $9.5B |
Data as of 4:00pm ET, 01/27/2021
Growth & Valuation
| Earnings growth (last year) | +56.99% |
| Earnings growth (this year) | -14.68% |
| Earnings growth (next 5 years) | +8.60% |
| Revenue growth (last year) | +2.64% |
| P/E ratio | NM |
| Price/Sales | 1.23 |
| Price/Book | 8.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| JAZZJazz Pharmaceuticals... | -2.14 | -1.29% |
| RAREUltragenyx Pharmaceu... | -4.01 | -2.86% |
| IONSIonis Pharmaceutical... | -3.31 | -5.29% |
| MRTXMirati Therapeutics ... | -9.84 | -4.83% |
Data as of 3:59pm ET, 01/27/2021
Financials
| Next reporting date | February 24, 2021 |
| EPS forecast (this quarter) | $1.09 |
| Annual revenue (last year) | $8.6B |
| Annual profit (last year) | -$1.8B |
| Net profit margin | -20.79% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Laval, Quă©bec |
Forecasts
